Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 01-2010 | 10-2009 | 07-2009 | 04-2009 | 01-2009 | |
| Sales | 67 | 96 | 130 | 67 | 129 |
| Cost of Goods | 66 | 124 | 118 | 120 | 185 |
| Gross Profit | 1 | -28 | 11 | -53 | -56 |
| Operating Expenses | 245 | 102 | 178 | 121 | 66 |
| Operating Income | -244 | -131 | -166 | -174 | -122 |
| Interest Expense | 39 | 38 | 42 | 39 | 41 |
| Other Income | 283 | 169 | 208 | 213 | 163 |
| Net Income Continuous | -283 | -169 | -208 | -213 | -163 |
| Net Income | $-283 | $-169 | $-208 | $-213 | $-163 |
| EPS Basic Total Ops | -0.82 | -0.27 | -0.82 | -1.09 | -1.09 |
| EPS Basic Continuous Ops | -0.82 | -0.27 | -0.82 | -1.09 | -1.09 |
| EPS Diluted Total Ops | -0.82 | -0.27 | -0.82 | -1.09 | -1.09 |
| EPS Diluted Continuous Ops | -0.82 | -0.27 | -0.82 | -1.09 | -1.09 |
| EBITDA(a) | $-208 | $-55 | $-102 | $-101 | $7 |